ÃÛ¶¹ÊÓƵ

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: ).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Critical infections

Faculty of Medicine / Department of Clinical Sciences, Lund / Section II / Anesthesiology and Intensive Care

Visiting address: Universitetssjukhuset, 22184 Lund

Description

Sepsis is caused by an inappropriate activation of the immune system in response to microbes. This leads to organ failure and in the worst cases septic shock, with 40-70 % mortality. We want to develop sepsis treatment by targeting bacterial products with specific drugs and by dialysis adsorbing the products. In the lab we study inflammatory responses to proteins from streptococci in immune cells and blood vessels. We identify the involved receptors with blockers, knock-out mice and recombinant cells. In a clinical study we compare dialysis using an endotoxin adsorbing filter with standard filter in sepsis patients. Why is this important? We have found that some streptococcal proteins activate innate immunity and affect blood vessels similar to during sepsis. Using blockers against the receptors involved we may modify the inflammation and restore the circulation in the patients. An endotoxin adsorbing dialysis filter is commercially available (oXiris) but clinical effects are unknown.

Staff

B

  • Ingrid Berkestedt

    Research project participant

    ingrid [dot] berkestedt [at] med [dot] lu [dot] se

  • Viveka Björck

    Research project participant

    viveka [dot] bjorck [at] med [dot] lu [dot] se

  • Mikael Bodelsson

    Project manager

    mikael [dot] bodelsson [at] med [dot] lu [dot] se

L

  • Dag Lundberg

    Research project participant

    dag [dot] lundberg [at] med [dot] lu [dot] se

N

  • Axel Nelson

    Research project participant

    axel [dot] nelson [at] med [dot] lu [dot] se

T

W